Clinical Trial Update: A Study Comparing SB2 to Remicade® in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy [Phase 3]

View source ↗

Summary

Phase 3 trial comparing SB2 to Remicade in moderate-to-severe rheumatoid arthritis patients on methotrexate completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Remicade (infliximab)
• SB2 (etanercept biosimilar)

Snippet

Sponsor: Samsung Bioepis Co., Ltd. | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2016-08-29